SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Septerna, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$36.38+0.03 (+0.08%)
Close on Oct 19, 2026
- Market cap
- $1.64B
- P/E (TTM)
- –
- Dividend yield
- –
Septerna statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Septerna | Industry median |
|---|---|---|
| Market Cap | $1.70B | $197.05M |
| Enterprise Value | $1.33B | $106.56M |
| PS Ratio | 17.17 | 3.93 |
| PB Ratio | 4.39 | 2.14 |
| P/TBV Ratio | 4.39 | 2.46 |
| P/FCF Ratio | 16.16 | 18.25 |
| P/OCF Ratio | 16.02 | 13.78 |
Enterprise value
| Measure | Septerna | Industry median |
|---|---|---|
| EV / Sales | 13.41 | 2.69 |
| EV / FCF | 12.61 | 21.02 |
Income (trailing twelve months)
| Measure | Septerna | Industry median |
|---|---|---|
| Revenue | $98.88M | $57.94M |
| Operating Income | -$43.55M | -$21.44M |
| Pretax Income | -$22.91M | -$14.45M |
| Net Income | -$24.24M | -$22.46M |
| EBITDA | -$41.95M | -$16.91M |
| EPS (Diluted) | -$0.54 | -$0.83 |
Margins
| Measure | Septerna | Industry median |
|---|---|---|
| Operating Margin | -44.0% | -44.5% |
| Pretax Margin | -23.2% | -13.0% |
| Profit Margin | -24.5% | -39.2% |
| EBITDA Margin | -42.4% | -31.3% |
| FCF Margin | 106.3% | -8.85% |
Returns
| Measure | Septerna | Industry median |
|---|---|---|
| Return on Equity (ROE) | -6.34% | -53.1% |
| Return on Assets (ROA) | -4.94% | -41.0% |
| Return on Invested Capital (ROIC) | -105.2% | -32.0% |
| Return on Capital Employed (ROCE) | -8.93% | -37.8% |
Growth
| Measure | Septerna | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 13520.1% | 6.01% |
Balance sheet
| Measure | Septerna | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $372.32M | $62.42M |
| Net Cash (Debt) | $372.32M | $15.68M |
| Net Cash Per Share | $7.98 | $0.65 |
| Equity (Book Value) | $386.72M | $48.79M |
| Book Value Per Share | $8.29 | $1.36 |
| Tangible Book Value | $386.72M | $23.06M |
| Working Capital | $316.84M | $75.77M |
Financial position
| Measure | Septerna | Industry median |
|---|---|---|
| Current Ratio | 4.99 | 3.30 |
| Quick Ratio | 4.85 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Septerna | Industry median |
|---|---|---|
| Operating Cash Flow | $106.01M | -$12.35M |
| Capital Expenditures | -$910.00K | -$1.06M |
| Free Cash Flow | $105.10M | -$20.28M |
| FCF Per Share | $2.25 | -$0.41 |
Efficiency
| Measure | Septerna | Industry median |
|---|---|---|
| Asset Turnover | 0.20 | 0.38 |
| Revenue Per Employee | $760.63K | $398.96K |
| Profits Per Employee | -$186.43K | -$732.08K |
| Employee Count | 130 | 73 |
Dividends and yields
| Measure | Septerna | Industry median |
|---|---|---|
| Earnings Yield | -1.43% | -21.2% |
| FCF Yield | 6.19% | -7.64% |
Shares
| Measure | Septerna | Industry median |
|---|---|---|
| Shares Outstanding | 46,676,900 | 59,128,900 |
| Shares Change (QoQ) | 1.67% | 0.54% |
| Float | 33,477,300 | 48,744,500 |
| Shares Held by Insiders | 28.3% | 11.8% |
| Shares Held by Institutions | 101.6% | 59.4% |
Taxes
| Measure | Septerna | Industry median |
|---|---|---|
| Income Tax | $1.32M | $91.50K |
Scores
| Measure | Septerna | Industry median |
|---|---|---|
| Altman Z-Score | 5.78 | 0.10 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Septerna's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.